{"SPADE_UN_16378": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16378", "Peptide Name": "H-57, Hymenochirin-1B [P5K,D9K; S4,T7,N10-GlcNAc; A18,A22 S5]", "Source": "Synthetic (Derived from Hymenochirin-1B)", "Family": "", "Gene": "Not found", "Sequence": "IKLXKEXKKXLKKVLKGXIKGXIAVAKMV", "Sequence Length": 29, "UniProt Entry": ["http://www.uniprot.org/uniprot/W8PRC4"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:A549 (IC50=1.10±0.31 μM); HCT 116 (IC50=1.65±0.28 μM); HepG2 (IC50=2.71±0.05 μM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C125H225N33O22S", "Mass": 362406, "PI": 11.34, "Net Charge": 8, "Hydrophobicity": 0.124, "Half Life": "Mammalian:20 hourYeast:30 minE.coli:>10 hour", "Literature": [{"Title": "Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B A Novel Glycosylated Staple Strategy", "Pubmed ID": "30789695", "Reference": "ACS Chem Biol. 2019 Mar 15;14(3)516-525.", "Author": "Li Y, Zhang Y, Wu M, Chang Q, Hu H, Zhao X.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=30789695"}], "Frequent Amino Acids": "KXI", "Absent Amino Acids": "CDFHNOPQRSTUWY", "Basic Residues": 9, "Acidic Residues": 1, "Hydrophobic Residues": 12, "Polar Residues": 14, "Positive Residues": 9, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_13416", "Similarity": 0.9583333333333334, "Sequence": "IKLSKETKDNLKKVLKGAIKGAIAVAKMV"}, {"SPADE_ID": "SPADE_UN_16379", "Similarity": 0.9583333333333334, "Sequence": "IKLKKKKLKKVLKGIKGIAVAKMV"}, {"SPADE_ID": "SPADE_UN_23805", "Similarity": 0.9583333333333334, "Sequence": "IKLSKTKKLKKVLKGAIKGAIAVAKMV"}]}}}